Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2020. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +29.35% | -5.45% | +200.58% |
1st Jan change | Capi. | |
---|---|---|
+200.58% | 98.81M | |
+8.14% | 3,022B | |
+4.28% | 81.91B | |
+3.40% | 76.64B | |
-16.54% | 52.31B | |
+35.85% | 51.96B | |
-22.85% | 47.77B | |
+23.11% | 43.3B | |
+64.59% | 38.29B | |
-14.17% | 25.1B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt